Therapeutic Solutions International Inc (TSOI)

[centsability4me]

they already do the checkpoint inhibitors

Ipilimumab (Yervoy) is a checkpoint inhibitor drug that blocks CTLA-4. It is a treatment for advanced melanoma and advanced renal cell cancer.

Therapeutic Solutions International Awarded Landmark Patent for Cancer and COVID-19 Treatment

https://www.yahoo.com/now/therapeutic-solutions-international-awarded-landmark-181700100.html

Numerous drugs such as Optivo®, Yervoy®, and Keytruda®, have been approved by the FDA for treatment of cancers by boosting immunity though blocking immune inhibiting mechanisms. This class of drugs, called "checkpoint inhibitors" represent a 15.2 billion dollar a year market.



Therapeutic Solutions International Reports its NanoStilbene™ Nutraceutical Product Enhances Efficacy of FDA Cleared Cancer Immunotherapy in Animal Model of Cancer

https://www.globenewswire.com/news-release/2019/07/22/1885810/0/en/Therapeutic-Solutions-International-Reports-its-NanoStilbene-Nutraceutical-Product-Enhances-Efficacy-of-FDA-Cleared-Cancer-Immunotherapy-in-Animal-Model-of-Cancer.html

NanoStilbene™ nutraceutical product [1] together with anti-CTLA4 antibody, which is the mouse equivalent of Ipilimumab (Yervoy®), an FDA cleared immunotherapeutic which belongs to the family of drugs called "checkpoint inhibitors". The new data supports the possibility that NanoStilbene™, a proprietary formulation of pterostilbene [2], may increase effectiveness of drugs that activate the immune system to kill cancer.